1. Home
  2. AIG vs NTRA Comparison

AIG vs NTRA Comparison

Compare AIG & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American International Group Inc. New

AIG

American International Group Inc. New

HOLD

Current Price

$79.20

Market Cap

41.7B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$270.18

Market Cap

40.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIG
NTRA
Founded
1919
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.7B
40.4B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
AIG
NTRA
Price
$79.20
$270.18
Analyst Decision
Hold
Strong Buy
Analyst Count
14
15
Target Price
$86.46
$259.07
AVG Volume (30 Days)
3.4M
1.6M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
2.44%
N/A
EPS Growth
350.23
0.65
EPS
1.41
N/A
Revenue
$26,775,000,000.00
$210,939,000.00
Revenue This Year
$11.55
$18.08
Revenue Next Year
$5.26
$19.65
P/E Ratio
$56.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.25
$131.81
52 Week High
$87.35
$288.04

Technical Indicators

Market Signals
Indicator
AIG
NTRA
Relative Strength Index (RSI) 58.91 62.72
Support Level $73.37 $186.96
Resistance Level $81.88 N/A
Average True Range (ATR) 1.80 13.06
MACD 0.43 0.81
Stochastic Oscillator 59.76 74.10

Price Performance

Historical Comparison
AIG
NTRA

About AIG American International Group Inc. New

American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: